Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human interferon α2b spray for pediatric herpangina
CTR20261766Phase 2Active
- Sponsor
- Beijing Kawin Technology Share-Holding Co., Ltd.
- Start
- May 2026
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa-2b in herpangina, sponsored by Beijing Kawin Technology Share-Holding Co., Ltd.. Started May 2026; status: active.
02
Drugs
interferon alfa-2b
03
Conditions
herpangina
Beyond the preview
Go deeper on CTR20261766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261766.